Short answer · Medically reviewed summary · Last updated: 2026-04-06
The primary treatment for Addison Disease is lifelong hormone replacement therapy, which involves daily oral administration of corticosteroids to replace the cortisol and aldosterone that the adrenal glands are no longer producing. First-Line Pharmacological Treatments To manage Addison Disease, physicians prescribe synthetic glucocorticoids, most commonly hydrocortisone (Cortef), to replace deficient cortisol. Many patients also require a mineralocorticoid, usually fludrocortisone (Florinef), to maintain blood pressure and electrolyte balance.
15 people with Addison Disease have shared their first-person experience on this question at DiseaseMaps.
The primary treatment for Addison Disease is lifelong hormone replacement therapy, which involves daily oral administration of corticosteroids to replace the cortisol and aldosterone that the adrenal glands are no longer producing.
To manage Addison Disease, physicians prescribe synthetic glucocorticoids, most commonly hydrocortisone (Cortef), to replace deficient cortisol. Many patients also require a mineralocorticoid, usually fludrocortisone (Florinef), to maintain blood pressure and electrolyte balance. Because every patient's metabolism is unique, your endocrinologist will tailor the dosage to your specific needs, often adjusting it during periods of physical stress, illness, or surgery to prevent an adrenal crisis.
While there is no surgical cure for Addison Disease, a multidisciplinary team is essential for long-term health. Your care team should include an endocrinologist as the lead specialist, supported by an emergency physician aware of your condition and a primary care doctor for general health screenings. Non-pharmacological management focuses on education, such as carrying an emergency medical ID bracelet and an injectable hydrocortisone kit, and maintaining a diet with adequate sodium intake, especially in hot weather.
Effectiveness of treatment for Addison Disease varies significantly between individuals; some patients feel well on standard twice-daily dosing, while others require modified-release formulations to better mimic the body's natural circadian rhythm. Clinical researchers are currently investigating subcutaneous cortisol pumps and novel once-daily dual-release hydrocortisone tablets, which aim to provide more stable hormone levels throughout the 24-hour cycle. These innovations offer hope for improving the quality of life for those living with the daily challenges of Addison Disease.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your endocrinologist or other qualified health provider regarding any medical condition or treatment adjustments.